Modelling vaccination schedules for a cancer immunoprevention vaccine
暂无分享,去创建一个
Filippo Castiglione | Francesco Pappalardo | Santo Motta | F. Pappalardo | S. Motta | P. Lollini | F. Castiglione | Pierluigi Lollini
[1] P. Delves,et al. The Immune System , 2000 .
[2] C. Wheeler,et al. A controlled trial of a human papillomavirus type 16 vaccine. , 2002, The New England journal of medicine.
[3] C. Hamers-Casterman,et al. A new allotype in the rabbit linked with As1 which may characterize a new class of IgG , 1966 .
[4] Piero Musiani,et al. Immunoprevention of HER-2/neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine , 2004, Cancer Research.
[5] Évin,et al. A CONTROLLED TRIAL OF A HUMAN PAPILLOMAVIRUS TYPE 16 VACCINE , 2022 .
[6] S. Rosenberg,et al. Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.
[7] P. Delves,et al. Advances in immunology: The immune system - Second of two parts. , 2000 .
[8] P. Matzinger,et al. An innate sense of danger. , 1998, Seminars in immunology.
[9] M. Pulvirenti,et al. Modelling in Applied Sciences: A Kinetic Theory Approach , 2004 .
[10] L. A. Segel,et al. Some Reflections on Memory in Shape Space , 1989 .
[11] M. Lai,et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. , 1997, The New England journal of medicine.
[12] L D Greller,et al. Tumor heterogeneity and progression: conceptual foundations for modeling. , 1996, Invasion & metastasis.
[13] M. Eaman. Immune system. , 2000, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[14] Vladimir Brusic,et al. Mathematical Modelling of the Immune System , 2004 .
[15] P. Musiani,et al. Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[16] Luigi Preziosi,et al. Modelling Mathematical Methods and Scientific Computation , 1995 .
[17] Luigi Preziosi,et al. Multiscale modeling and mathematical problems related to tumor evolution and medical therapy. , 2003 .
[18] Filippo Castiglione,et al. Modeling and simulation of cancer immunoprevention vaccine , 2005, Bioinform..
[19] P. Musiani,et al. Immunoprevention of cancer: is the time ripe? , 2000, Cancer research.
[20] G. Trinchieri,et al. Interleukin-12 in anti-tumor immunity and immunotherapy. , 2002, Cytokine & growth factor reviews.